Syndax Pharmaceuticals Inc (SNDX)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track Share on 𝕏

Stock chart
Ticker: SNDX Exchange: NSM


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale
Past 90 days
 
Value bought
 
Value sold
 
Net insiders buying
 
Trades (buy and sell)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Total value Details
2023-08-10 2023-08-09 S Sale

Morrison Briggs

Non-Executive Director
52,855 -74.8%
18.27
965,402 USD 		52,855 -74.8% 18.27 965,402 USD
2023-08-03 2023-08-02 S Sale

Meury William

Non-Executive Director
24,000 -33.3%
20.45
490,913 USD 		24,000 -33.3% 20.45 490,913 USD
2023-08-03 2023-08-02 S Sale

Meury William

Non-Executive Director
24,000 -33.3%
20.46
490,951 USD 		24,000 -33.3% 20.46 490,951 USD
2023-08-03 2023-08-02 S Sale

Meury William

Non-Executive Director
35,000 -42.2%
20.46
715,946 USD 		35,000 -42.2% 20.46 715,946 USD
2023-07-11 2023-07-10 S Sale

Morrison Briggs

Non-Executive Director
52,855 -74.8%
20.40
1,078,068 USD 		52,855 -74.8% 20.40 1,078,068 USD
2023-06-14 2023-06-13 S Sale

Goldan Keith A.

Chief Financial Officer

Officer
577 -18.0%
22.31
12,873 USD 		577 -18.0% 22.31 12,873 USD
2023-06-09 2023-06-09 S Sale

Morrison Briggs

Non-Executive Director
28,273 -61.3%
21.18
598,797 USD 		28,273 -61.3% 21.18 598,797 USD
2023-06-09 2023-06-09 S Sale

Morrison Briggs

Non-Executive Director
24,582 -34.8%
21.18
520,625 USD 		24,582 -34.8% 21.18 520,625 USD
2023-05-10 2023-05-09 S Sale

Morrison Briggs

Non-Executive Director
52,855 -74.8%
21.41
1,131,478 USD 		52,855 -74.8% 21.41 1,131,478 USD
2023-04-12 2023-04-10 S Sale

Morrison Briggs

Non-Executive Director
52,855 -74.8%
19.53
1,032,237 USD 		52,855 -74.8% 19.53 1,032,237 USD
2023-03-14 2023-03-13 PS Planned sale

Morrison Briggs

President, Head of R&D

Executive Director
52,854 -74.8%
22.53
1,190,674 USD 		52,854 -74.8% 22.53 1,190,674 USD
2023-02-17 2023-02-15 PS Planned sale

Ordentlich Peter

Chief Scientific Officer

Officer
17,428 -100.0%
25.84
450,404 USD 		17,428 -100.0% 25.84 450,404 USD
2023-02-17 2023-02-15 PS Planned sale

Ordentlich Peter

Chief Scientific Officer

Officer
7,572 -100.0%
25.84
195,688 USD 		7,572 -100.0% 25.84 195,688 USD
2023-02-08 2023-02-06 PS Planned sale

Morrison Briggs

President, Head of R&D

Executive Director
52,854 -74.8%
26.83
1,417,909 USD 		52,854 -74.8% 26.83 1,417,909 USD
2023-02-08 2023-02-06 PS Planned sale

Metzger Michael A

Chief Executive Officer

Executive Director
5,959 -25.2%
27.64
164,697 USD 		5,959 -25.2% 27.64 164,697 USD
2023-02-03 2023-02-01 S Sale

Ordentlich Peter

Chief Scientific Officer

Officer
69 -100.0%
28.43
1,962 USD 		69 -100.0% 28.43 1,962 USD
2023-01-13 2023-01-13 PS Planned sale

Legault Pierre

Non-Executive Director
5,000 -13.5%
27.00
135,000 USD 		5,000 -13.5% 27.00 135,000 USD
2023-01-13 2023-01-13 PS Planned sale

Legault Pierre

Non-Executive Director
10,000 -23.8%
27.00
270,000 USD 		10,000 -23.8% 27.00 270,000 USD
2023-01-13 2023-01-12 PS Planned sale

Legault Pierre

Non-Executive Director
24,000 -42.9%
26.74
641,782 USD 		24,000 -42.9% 26.74 641,782 USD
2022-12-02 2022-12-02 PS Planned sale

Ordentlich Peter

Chief Scientific Officer

Officer
17,200 -98.5%
25.05
430,936 USD 		17,200 -98.5% 25.05 430,936 USD
2022-12-02 2022-12-01 PS Planned sale

Ordentlich Peter

Chief Scientific Officer

Officer
4,028 -93.8%
25.01
100,746 USD 		4,028 -93.8% 25.01 100,746 USD
2022-12-02 2022-12-01 PS Planned sale

Ordentlich Peter

Chief Scientific Officer

Officer
3,772 -93.4%
25.01
94,343 USD 		3,772 -93.4% 25.01 94,343 USD
2022-10-07 2022-10-06 PS Planned sale

Katkin Keith

Non-Executive Director
9,117 -22.2%
25.90
236,139 USD 		9,117 -22.2% 25.90 236,139 USD
2022-10-07 2022-10-06 PS Planned sale

Katkin Keith

Non-Executive Director
20,782 -39.4%
25.90
538,273 USD 		20,782 -39.4% 25.90 538,273 USD
2022-10-07 2022-10-06 PS Planned sale

Metzger Michael A

Chief Executive Officer

Executive Director
16,231 -47.9%
25.29
410,508 USD 		16,231 -47.9% 25.29 410,508 USD
2022-10-04 2022-10-04 PS Planned sale

Metzger Michael A

Chief Executive Officer

Executive Director
1,280 -6.8%
25.02
32,026 USD 		1,280 -6.8% 25.02 32,026 USD
2022-10-04 2022-10-04 PS Planned sale

Katkin Keith

Non-Executive Director
223 -0.7%
25.00
5,575 USD 		223 -0.7% 25.00 5,575 USD
2022-10-04 2022-10-04 PS Planned sale

Katkin Keith

Non-Executive Director
137 -0.4%
25.00
3,425 USD 		137 -0.4% 25.00 3,425 USD
2022-10-04 2022-10-03 PS Planned sale

Metzger Michael A

Chief Executive Officer

Executive Director
2,883 -14.0%
25.01
72,107 USD 		2,883 -14.0% 25.01 72,107 USD
2022-10-04 2022-10-03 PS Planned sale

Katkin Keith

Non-Executive Director
13 -0.0%
25.00
325 USD 		13 -0.0% 25.00 325 USD
2022-10-04 2022-10-03 PS Planned sale

Katkin Keith

Non-Executive Director
167 -0.5%
25.00
4,175 USD 		167 -0.5% 25.00 4,175 USD
2022-10-04 2022-09-30 PS Planned sale

Metzger Michael A

Chief Executive Officer

Executive Director
29,606 -62.6%
25.02
740,757 USD 		29,606 -62.6% 25.02 740,757 USD
2022-10-04 2022-09-30 PS Planned sale

Katkin Keith

Non-Executive Director
647 -2.0%
25.07
16,221 USD 		647 -2.0% 25.07 16,221 USD
2022-10-04 2022-09-30 PS Planned sale

Katkin Keith

Non-Executive Director
2,914 -8.3%
25.07
73,056 USD 		2,914 -8.3% 25.07 73,056 USD
2022-09-21 2022-09-20 PS Planned sale

Morrison Briggs

President, Head of R&D

Executive Director
59,649 -77.0%
23.25
1,387,012 USD 		59,649 -77.0% 23.25 1,387,012 USD
2022-09-21 2022-09-19 PS Planned sale

Morrison Briggs

President, Head of R&D

Executive Director
114,339 -86.5%
23.03
2,633,044 USD 		114,339 -86.5% 23.03 2,633,044 USD
2022-09-16 2022-09-16 PS Planned sale

Podlesak Dennis

Non-Executive Director
6,556 -8.0%
23.43
153,625 USD 		6,556 -8.0% 23.43 153,625 USD
2022-09-16 2022-09-16 PS Planned sale

Podlesak Dennis

Non-Executive Director
5,419 -6.7%
23.43
126,982 USD 		5,419 -6.7% 23.43 126,982 USD
2022-09-16 2022-09-16 PS Planned sale

Morrison Briggs

President, Head of R&D

Executive Director
53,034 -74.8%
23.22
1,231,423 USD 		53,034 -74.8% 23.22 1,231,423 USD
2022-09-16 2022-09-16 PS Planned sale

Morrison Briggs

President, Head of R&D

Executive Director
71,966 -80.1%
23.22
1,671,015 USD 		71,966 -80.1% 23.22 1,671,015 USD
2022-09-16 2022-09-15 PS Planned sale

Podlesak Dennis

Non-Executive Director
66,840 -46.9%
24.20
1,617,381 USD 		66,840 -46.9% 24.20 1,617,381 USD
2022-09-16 2022-09-15 PS Planned sale

Morrison Briggs

President, Head of R&D

Executive Director
66,775 -78.9%
24.20
1,616,035 USD 		66,775 -78.9% 24.20 1,616,035 USD
2022-09-16 2022-09-14 PS Planned sale

Morrison Briggs

President, Head of R&D

Executive Director
87,645 -83.1%
23.80
2,085,855 USD 		87,645 -83.1% 23.80 2,085,855 USD
2022-08-26 2022-08-24 PS Planned sale

Ordentlich Peter

Chief Scientific Officer

Officer
2,154 -89.0%
25.04
53,927 USD 		2,154 -89.0% 25.04 53,927 USD
2022-08-26 2022-08-24 PS Planned sale

Ordentlich Peter

Chief Scientific Officer

Officer
22,846 -98.9%
25.04
571,966 USD 		22,846 -98.9% 25.04 571,966 USD
2022-08-09 2022-08-05 PS Planned sale

Legault Pierre

Non-Executive Director
14,000 -30.4%
23.02
322,223 USD 		14,000 -30.4% 23.02 322,223 USD
2022-08-09 2022-08-05 PS Planned sale

Legault Pierre

Non-Executive Director
10,000 -23.8%
23.02
230,159 USD 		10,000 -23.8% 23.02 230,159 USD
2022-07-27 2022-07-25 PS Planned sale

Metzger Michael A

Chief Executive Officer

Executive Director
11,838 -40.1%
21.06
249,254 USD 		11,838 -40.1% 21.06 249,254 USD
2022-07-27 2022-07-25 PS Planned sale

Metzger Michael A

Chief Executive Officer

Executive Director
19,764 -52.8%
21.06
416,139 USD 		19,764 -52.8% 21.06 416,139 USD
2022-07-08 2022-07-07 PS Planned sale

Metzger Michael A

Chief Executive Officer

Executive Director
100 -0.6%
21.00
2,100 USD 		100 -0.6% 21.00 2,100 USD
2022-07-08 2022-07-06 PS Planned sale

Metzger Michael A

Chief Executive Officer

Executive Director
15,009 -45.9%
21.07
316,307 USD 		15,009 -45.9% 21.07 316,307 USD
2022-07-05 2022-07-01 PS Planned sale

Morrison Briggs

President, Head of R&D

Executive Director
62,292 -77.7%
19.00
1,183,430 USD 		62,292 -77.7% 19.00 1,183,430 USD
2022-04-05 2022-04-04 PS Planned sale

Morrison Briggs

President, Head of R&D

Executive Director
3,128 -14.9%
18.29
57,220 USD 		3,128 -14.9% 18.29 57,220 USD
2022-04-05 2022-04-01 PS Planned sale

Morrison Briggs

President, Head of R&D

Executive Director
70,545 -79.8%
17.46
1,231,568 USD 		70,545 -79.8% 17.46 1,231,568 USD
2022-04-05 2022-04-01 PS Planned sale

Morrison Briggs

President, Head of R&D

Executive Director
24,500 -57.9%
17.44
427,314 USD 		24,500 -57.9% 17.44 427,314 USD
2022-04-05 2022-04-01 PS Planned sale

Morrison Briggs

President, Head of R&D

Executive Director
6,000 -12.4%
17.44
104,633 USD 		6,000 -12.4% 17.44 104,633 USD
2022-02-03 2022-02-01 S Sale

Nolte Alexander

Chief Accounting Officer

Officer
968 -100.0%
16.65
16,117 USD 		968 -100.0% 16.65 16,117 USD
2022-02-03 2022-02-01 S Sale

Ordentlich Peter

Chief Scientific Officer

Officer
1,412 -100.0%
16.65
23,510 USD 		1,412 -100.0% 16.65 23,510 USD
2021-12-22 2021-12-22 PS Planned sale

Legault Pierre

Non-Executive Director
24,000 -60.0%
22.01
528,206 USD 		24,000 -60.0% 22.01 528,206 USD
2021-12-22 2021-12-20 PS Planned sale

Legault Pierre

Non-Executive Director
20,000 -55.6%
21.01
420,250 USD 		20,000 -55.6% 21.01 420,250 USD
2021-12-20 2021-12-20 PS Planned sale

Metzger Michael A

President and COO

Executive Director
45,000 -71.8%
20.29
912,960 USD 		45,000 -71.8% 20.29 912,960 USD
2021-12-20 2021-12-20 PS Planned sale

Metzger Michael A

President and COO

Executive Director
16,000 -47.5%
20.29
324,608 USD 		16,000 -47.5% 20.29 324,608 USD
2021-12-20 2021-12-17 PS Planned sale

Metzger Michael A

President and COO

Executive Director
1,676 -8.7%
19.02
31,877 USD 		1,676 -8.7% 19.02 31,877 USD
2021-12-20 2021-12-17 PS Planned sale

Morrison Briggs

Chief Executive Officer

Executive Director
35,156 -42.1%
20.00
703,120 USD 		35,156 -42.1% 20.00 703,120 USD
2021-12-20 2021-12-16 PS Planned sale

Metzger Michael A

President and COO

Executive Director
22,715 -56.3%
19.08
433,400 USD 		22,715 -56.3% 19.08 433,400 USD
2021-12-15 2021-12-13 PS Planned sale

Metzger Michael A

President and COO

Executive Director
34,564 -66.2%
19.05
658,555 USD 		34,564 -66.2% 19.05 658,555 USD
2021-12-15 2021-12-13 PS Planned sale

Metzger Michael A

President and COO

Executive Director
2,045 -10.4%
19.05
38,964 USD 		2,045 -10.4% 19.05 38,964 USD
2021-11-19 2021-11-18 PS Planned sale

Egros Fabrice

Non-Executive Director
30 -0.2%
18.03
541 USD 		30 -0.2% 18.03 541 USD
2021-11-19 2021-11-18 PS Planned sale

Egros Fabrice

Non-Executive Director
14,000 -46.7%
18.03
252,452 USD 		14,000 -46.7% 18.03 252,452 USD
2021-10-27 2021-10-26 PS Planned sale

Metzger Michael A

President and COO

Executive Director
16,296 -48.0%
19.20
312,825 USD 		16,296 -48.0% 19.20 312,825 USD
2021-10-27 2021-10-25 PS Planned sale

Metzger Michael A

President and COO

Executive Director
44,704 -71.7%
19.13
855,335 USD 		44,704 -71.7% 19.13 855,335 USD
2021-09-28 2021-09-27 PS Planned sale

Metzger Michael A

President and COO

Executive Director
24,437 -58.1%
19.51
476,832 USD 		24,437 -58.1% 19.51 476,832 USD
2021-08-20 2021-08-18 PS Planned sale

Egros Fabrice

Non-Executive Director
15,635 -49.4%
15.75
246,328 USD 		15,635 -49.4% 15.75 246,328 USD
2021-05-20 2021-05-18 PS Planned sale

Egros Fabrice

Non-Executive Director
1,683 -9.5%
18.65
31,385 USD 		1,683 -9.5% 18.65 31,385 USD
2021-05-20 2021-05-18 PS Planned sale

Egros Fabrice

Non-Executive Director
11,926 -40.3%
18.65
222,398 USD 		11,926 -40.3% 18.65 222,398 USD